Joseph Brenner

553 total citations
18 papers, 412 citations indexed

About

Joseph Brenner is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Joseph Brenner has authored 18 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Reproductive Medicine. Recurrent topics in Joseph Brenner's work include Ovarian cancer diagnosis and treatment (5 papers), Occupational and environmental lung diseases (5 papers) and Testicular diseases and treatments (4 papers). Joseph Brenner is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Occupational and environmental lung diseases (5 papers) and Testicular diseases and treatments (4 papers). Joseph Brenner collaborates with scholars based in United States, Israel and Russia. Joseph Brenner's co-authors include Peter P. Sordillo, Gordon B. Magill, Robert B. Golbey, Davor Vugrin, Willet F. Whitmore, Edgar Cheng, Joseph Menczer, Michaela Modan, Gilad Ben‐Baruch and Hermann Brenner and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and Urology.

In The Last Decade

Joseph Brenner

16 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Brenner United States 11 313 106 82 62 58 18 412
Maryam Kadivar Iran 12 91 0.3× 100 0.9× 121 1.5× 26 0.4× 31 0.5× 40 341
R. N. HITCHINS United Kingdom 7 298 1.0× 151 1.4× 203 2.5× 16 0.3× 17 0.3× 11 438
E. Stoeckle France 8 196 0.6× 105 1.0× 114 1.4× 88 1.4× 78 1.3× 15 374
Julian Money‐Kyrle United Kingdom 8 89 0.3× 77 0.7× 62 0.8× 22 0.4× 41 0.7× 11 204
William Friedel United States 7 249 0.8× 59 0.6× 26 0.3× 31 0.5× 25 0.4× 8 309
Spjut Hj United States 9 127 0.4× 85 0.8× 36 0.4× 16 0.3× 108 1.9× 20 277
Dina Lev‐Chelouche Israel 11 175 0.6× 282 2.7× 194 2.4× 19 0.3× 71 1.2× 18 449
Filiz Özyılmaz Türkiye 10 89 0.3× 128 1.2× 49 0.6× 16 0.3× 18 0.3× 28 269
Hiroshi Nanjyo Japan 9 101 0.3× 94 0.9× 57 0.7× 141 2.3× 23 0.4× 29 390
Harika Tirumani United States 10 208 0.7× 88 0.8× 59 0.7× 20 0.3× 70 1.2× 22 303

Countries citing papers authored by Joseph Brenner

Since Specialization
Citations

This map shows the geographic impact of Joseph Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Brenner more than expected).

Fields of papers citing papers by Joseph Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Brenner. The network helps show where Joseph Brenner may publish in the future.

Co-authorship network of co-authors of Joseph Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Brenner. A scholar is included among the top collaborators of Joseph Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Brenner. Joseph Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Brenner, Joseph, et al.. (2023). Watchful Eye Prevents Catastrophe in Case of Malignant Hyperthermia. JBJS Case Connector. 13(3).
4.
Ron, Ilan G., Nely Wigler, Riva Borovik, et al.. (2002). CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer. American Journal of Clinical Oncology. 25(5). 520–522. 1 indexed citations
5.
Ron, Ilan G., Nely Wigler, Riva Borovik, et al.. (2001). CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer. American Journal of Clinical Oncology. 24(4). 323–327. 7 indexed citations
6.
Sordillo, Peter P., Gordon B. Magill, Joseph Brenner, et al.. (1987). Cisplatin. A phase II evaluation in previously untreated patients with soft tissue sarcomas. Cancer. 59(5). 884–886. 13 indexed citations
7.
Menczer, Joseph, et al.. (1986). A comparison of low- and high-dose cisplatin-based combination chemotherapy as initial postoperative treatment in advanced ovarian adenocarcinoma. American Journal of Obstetrics and Gynecology. 155(5). 974–979. 6 indexed citations
8.
Menczer, Joseph, Michaela Modan, Joseph Brenner, Gilad Ben‐Baruch, & Hermann Brenner. (1986). Abdominopelvic irradiation for stage II–IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy. Gynecologic Oncology. 24(2). 149–154. 20 indexed citations
9.
Brenner, Joseph, Davor Vugrin, & Willet F. Whitmore. (1985). Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis. American Journal of Clinical Oncology. 8(2). 178–182. 24 indexed citations
10.
Menczer, Joseph, Gilad Ben‐Baruch, Michaela Modan, Joseph Brenner, & Hermann Brenner. (1984). A comparison of postoperative radiotherapy with postoperative chemotherapy in stage II–IV ovarian cancer patients. Gynecologic Oncology. 17(2). 207–212. 6 indexed citations
11.
Brenner, Joseph, Gordon B. Magill, Paul Wissel, & Peter P. Sordillo. (1983). Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC). Cancer. 52(7). 1142–1145. 10 indexed citations
12.
Brenner, Joseph, Gordon B. Magill, Peter P. Sordillo, Edgar Cheng, & A Yagoda. (1982). Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma. Cancer. 50(10). 2031–2033. 23 indexed citations
13.
Brenner, Joseph, Peter P. Sordillo, Gordon B. Magill, & Robert B. Golbey. (1982). Malignant mesothelioma of the pleura: Review of 123 patients. Cancer. 49(11). 2431–2435. 173 indexed citations
14.
Brenner, Joseph, Davor Vugrin, & Willet F. Whitmore. (1982). Cytoreductive surgery for advanced nonseminomatous germ cell tumors of testis. Urology. 19(6). 571–575. 11 indexed citations
15.
Brenner, Joseph, Peter P. Sordillo, & Gordon B. Magill. (1981). Malignant mesothelioma in children: Report of seven cases and review of the literature. Medical and Pediatric Oncology. 9(4). 367–373. 50 indexed citations
16.
Brenner, Joseph, Peter P. Sordillo, Gordon B. Magill, & Robert B. Golbey. (1981). Malignant peritoneal mesothelioma: review of 25 patients.. PubMed. 75(4). 311–3. 39 indexed citations
17.
Brenner, Joseph, Peter P. Sordillo, & Gordon B. Magill. (1981). An unusual presentation of malignant mesothelioma: The incidental finding of tumor in the hernia sac during herniorrhaphy. Journal of Surgical Oncology. 18(2). 159–161. 13 indexed citations
18.
Brenner, Joseph, et al.. (1981). Seventeen year survival in a patient with malignant peritoneal mesothelioma.. PubMed. 7(3). 249–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026